2024
|
Invention
|
Expression of biomolecules with improved promoter and tir. The present disclosure describes genet... |
|
Invention
|
Non-therapeutic and therapeutic use of hydroxycinnamic acid & derivatives. The present invention ... |
|
Invention
|
A low dose formulation of l-serine for liver health and fatty liver diseases. The present inventi... |
|
G/S
|
Fermentation extract; Fermentation extracts for industrial purposes; Sulfates; Flavonoids [phenol... |
2023
|
Invention
|
Genetically modified host cells producing l-serine. The present invention relates to a geneticall... |
|
Invention
|
Method to inhibit proliferation of a phytopathogen on plants and compositions used for this purpo... |
|
Invention
|
Method to inhibit proliferation of a phytopathogen on plants and compositions used for this purpose |
|
Invention
|
Production of cysteine or cystine from serine in fermentation medium. The present disclosure desc... |
|
G/S
|
Amino acids for industrial purposes; Amino acids for scientific purposes; Fermentation extract; F... |
2022
|
Invention
|
Biological processes for the production of aryl sulfates. The present invention generally relates... |
2021
|
Invention
|
Escerichia coli. The present invention generally relates to the field of biotechnology as it appl... |
2020
|
Invention
|
Genetically modified microorganisms having improved tolerance towards l-serine. The present inven... |
|
Invention
|
Processes for the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia ... |
2017
|
Invention
|
Escherichia coli having an increased expression of a cysp transporter, an atp sulfurylase, an aps... |
2016
|
Invention
|
Method for the production of l-serine using genetically engineered microorganisms deficient in se... |
2015
|
Invention
|
Biological processes for the production of aryl sulfates.
The present invention generally relate... |
|
Invention
|
Process for producing a fermentation product from a lignocellulose-containing material. The prese... |